SEC Form 4 · accession 0000891293-15-000002
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Bianco
Officer — President and CEO · Director
Period of report
Jan 8, 2015
Accepted (ET)
Jan 9, 2015 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2015 | A | 1,590,850 | $0.00 | A | 3,501,576 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents a grant by CTIC of restricted stock. The grant is scheduled to vest as to one-thrid of the shares on each of March 21, 2015, September 21, 2015, and March 21, 2016.